Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Vangeneugden

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Biometrics|December 21, 2004
Validation of surrogate markers in multiple randomized clinical trials with repeated measurements: canonical correlation approachAriel Alonso, Helena Geys, Geert Molenberghs, et al.
Journal of Psychiatric Research|November 7, 2008
Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scalesAnnouschka Laenen, Ariel Alonso, Geert Molenberghs, et al.
British Journal of Clinical Pharmacology|May 8, 2008
Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteersVanitha J Sekar, Eric Lefebvre, Martine De Pauw, et al.
Therapeutic Drug Monitoring|November 29, 2007
Pharmacokinetic interaction between darunavir and saquinavir in HIV-negative volunteersVanitha J Sekar, Eric Lefebvre, Kris Mariën, et al.
Journal of Clinical Pharmacology|April 28, 2010
Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxoneVanitha Sekar, Frank Tomaka, Eric Lefebvre, et al.
British Journal of Clinical Pharmacology|August 8, 2009
Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patientsVanitha Sekar, Eric Lefebvre, Kris Mariën, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2014
Pharmacokinetics and pharmacodynamics of boosted once-daily darunavirThomas N Kakuda, Anne Brochot, Frank L Tomaka, et al.
Intervirology|March 4, 2010
Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteersVanitha Sekar, Eric Lefebvre, Tine De Marez, et al.
Antiviral Therapy|August 5, 2008
Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy womenVanitha J Sekar, Eric Lefebvre, Sabrina Spinosa Guzman, et al.
Clinical Trials (London, England)|January 16, 2016
Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challengesAn Vandebosch, Robin Mogg, Nele Goeyvaerts, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Biometrics|December 21, 2004
Validation of surrogate markers in multiple randomized clinical trials with repeated measurements: canonical correlation approachAriel Alonso, Helena Geys, Geert Molenberghs, et al.
Journal of Psychiatric Research|November 7, 2008
Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scalesAnnouschka Laenen, Ariel Alonso, Geert Molenberghs, et al.
British Journal of Clinical Pharmacology|May 8, 2008
Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteersVanitha J Sekar, Eric Lefebvre, Martine De Pauw, et al.
Therapeutic Drug Monitoring|November 29, 2007
Pharmacokinetic interaction between darunavir and saquinavir in HIV-negative volunteersVanitha J Sekar, Eric Lefebvre, Kris Mariën, et al.
Journal of Clinical Pharmacology|April 28, 2010
Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxoneVanitha Sekar, Frank Tomaka, Eric Lefebvre, et al.
British Journal of Clinical Pharmacology|August 8, 2009
Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patientsVanitha Sekar, Eric Lefebvre, Kris Mariën, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2014
Pharmacokinetics and pharmacodynamics of boosted once-daily darunavirThomas N Kakuda, Anne Brochot, Frank L Tomaka, et al.
Intervirology|March 4, 2010
Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteersVanitha Sekar, Eric Lefebvre, Tine De Marez, et al.
Antiviral Therapy|August 5, 2008
Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy womenVanitha J Sekar, Eric Lefebvre, Sabrina Spinosa Guzman, et al.
Clinical Trials (London, England)|January 16, 2016
Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challengesAn Vandebosch, Robin Mogg, Nele Goeyvaerts, et al.
Pageof 4